Abstract
Renal cell carcinoma (RCC) are frequently chemo- and radiation resistant. Thus, there is a need for identifying biological features of these cells that could serve as alternative therapeutic targets. We performed suppression subtractive hybridization (SSH) on patient-matched normal renal and RCC tissue to identify variably regulated genes. 11 genes were strongly up-regulated or selectively expressed in more than one RCC tissue or cell line. Screening of filters containing cancer-related cDNAs confirmed overexpression of 3 of these genes and 3 additional genes were identified. These 14 differentially expressed genes, only 6 of which have previously been associated with RCC, are related to tumour growth/survival (EGFR, cyclin D1, insulin-like growth factor-binding protein-1 and a MLRQ sub-unit homologue of the NADH:ubiquinone oxidoreductase complex), angiogenesis (vascular endothelial growth factor, endothelial PAS domain protein-1, ceruloplasmin, angiopoietin-related protein 2) and cell adhesion/motility (protocadherin 2, cadherin 6, autotaxin, vimentin, lysyl oxidase and semaphorin G). Since some of these genes were overexpressed in 80–90% of RCC tissues, it is important to evaluate their suitability as therapeutic targets. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Avantagiatti ML (2000) Molecular horizons of cancer therapeutics. Biochim Biophys Acta 1470: 49–59
Bartkova J, Lukas J, Strauss M and Bartek J (1994) The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 58: 568–573
Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Ciltron M and Vassar R (2000) Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem 275: 20647–20651
Brambilla E, Constantin B, Drabkin H and Roche J (2000) Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. Am J Pathol 156: 939–950
Bremers AJ and Parmiani G (2000) Tumour immunotherapy: the adjuvant treatment of the 21st century?. Crit Rev Oncol Hematol 34: 1–25
Brown JM (1999) The hypoxic cell: a target for selective cancer therapy. Cancer Res 59: 5863–5870
Bukowski RM (2000) Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma. Semin Oncol 27: 204–212
Christensen CR, Klingelhofer J, Tarabykina S, Hulgaard EF, Kramerov D and Lukanidin E (1998) Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res 58: 1238–1244
Conover CA and Powell DR (1991) Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 129: 710–716
Conrad PW, Freeman TL, Beitner-Johnson D and Millhorn DE (1999) EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem 274: 33709–33713
De Plaen E, Lurquin C, Van Pel A, Mariame B, Szikora J, Wölfel T, Sibille C, Chomez P and Boon T (1988) Immunogenic (tum-) variants of mouse tumor P815. Cloning of the gene of tum-antigen P91A and identification of the tum-mutation. Proc Natl Acad Sci USA 85: 2274–2278
Freeman MR, Washecka R and Chung LW (1989) Aberrant expression of epidermal growth factor receptor and HER-2 (erB-2) messenger RNAs in hman renal cancers. Cancer Res 49: 6221–6225
Gerwins P, Skoldenberg E and Claesson-Welsh L (2000) Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 34: 185–194
Harris SR and Thorgeirsson UP (1998) Tumor angiogenesis: biology and therapeutic prospects. In Vivo 12: 563–570
Hedberg Y, Davoodi E, Roos G, Ljungberg B and Landberg G (1999) Cyclin-D1 expression in human renal cell carcinoma. Int J Cancer 84: 268–272
Hendrix MJ, Seftor EA, Chu YW, Trevor KT and Seftor RE (1996) Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 15: 507–525
Hoffman DM, Gitlitz BJ, Belldegrun A and Figlin RA (2000) Adoptive cellular therapy. Semin Oncol 27: 221–233
Hofmockel G, Tack W and Frohmuller HG (1997) Cyclic interferon alpha treatment in metastatic renal cell carcinoma: results of a phase II study and review of the literature. Urol Int 58: 8–12
Huang YW, Baluna R and Vitetta ES (1997) Adhesion molecules as targets for cancer therapy. Histol Histopathol 12: 467–477
Ishikawa J, Maeda S, Umezu K, Sugiyama T and Kamidono S (1990) Amplification and overexpression of the epidermal growth factor receptor gene in human renal cell carcinoma. Int J Cancer 45: 1018–1021
Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J and Cardesa A (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54: 4813–4817
Kanapuli SP, Singh H, Singh P and Kumar A (1987) Ceruloplasmin gene expression in human cancer cells. Life Sci 40: 2225–2228
Kaplan CD, Morris JR, Wu C and Winston F (2000) Spt5 and spt are associated with active transcription and have characteristics of general elongation factors in D.melanogaster. Genes Dev 14: 2623–2634
Kawagoe H, Stracke ML, Nakamura H and Sano K (1997) Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma. Cancer Res 57: 2516–2521
Kerbel RS (2000) Tumor angiogenesis: past, present and the near future. Carcinogenesis 21: 505–515
Khan J, Bittner ML, Chen Y, Meltzer PS and Trent JM (1999). Biochim Biophys Acta 1423: 17–28
Kim I, Moon SO, Koh KN, Kim H, Uhm CS, Kwak HJ, Kim NG and Koh GY (1999) Molecular cloning, expression and characterization of angiopoietin-related protein. J Biol Chem 274: 26523–26528
Kirschmann DA, Seftor EA, Nieva DR, Mariano EA and Hendrix MJ (1999) Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat 55: 127–136
Kuang WW, Thompson DA, Hoch RV and Weigel RJ (1998) Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma line. Nucleic Acid Res 26: 1116–1123
Kunkel LM, Monaco AP, Middlesworth W, Ochs HD and Latt SA (1995) Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci USA 82: 4778–4782
Kurzrock R, Ku S and Talpaz M (1995) Abnormalities in the PRAD1 (cyclin d1/bcl-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma lines. Cancer 75: 584–590
Lager DJ, Slagel DD and Palechek PL (1994) The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. Mod Pathol 7: 544–548
Lamar EE and Palmer E (1984) Y-encoded species-specific DNA in mice: evidence that the Y chromosome exists in two polymorphic forms in inbred strains. Cell 37: 171–177
Lee HY, Murata J, Clair T, Polymeropoulos MH, Torres R, Manrow RE, Liotta LA and Stracke ML (1996) Cloning, chromosomal localization and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun 218: 714–719
Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagishawa K, Tomisawa M, Fukada H, Nakano H, Abe S, Tateishi A, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y and Nakamura M (1999) Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 35: 1089–1093
Li YM, Schacher DH, Liu Q, Arkins S, Rebeitz N, McCusker RH Jr, Dantzer R and Kelley KW (1997) Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor. Endocrinology 138: 362–368
Liang P and Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of polymerase chain reaction. Science 257: 967–971
Lin BT, Brynes RK, Gelb AB, McCourty A, Amin MB and Medeiros LJ (1998) Cyclin D1 expression in renal cell carcinomas and oncocytomas: an immunohistochemical study. Med Pathol 11: 1075–1081
Mark MD, Lohrum M and Püschel AW (1997) Patterning neuronal connections by chemorepulsion: the semaphorins. Cell Tissue Res 290: 299–306
Martin-Satue M and Blanco J (1999) Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA. J Surg Oncol 72: 18–23
Mickisch GH (1994) Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity?. World J Urol 12: 214–223
Meng JY, Kataoka H, Itoh H and Koono M (2001) Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int J Cancer 92: 31–39
Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP and Sauter G (1999) High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154: 981–986
Moch H, Gasser T, Amin MB, Torhorst J, Sauter G and Mihatsch MJ (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 89: 604–614
Motzer RJ and Russo P (2000) Systemic therapy for renal cell carcinoma. J Urol 163: 408–417
Nieder C, Niewald M and Schnabel K (1996) Treatment of brain metastases from hypernephroma. Urol Int 57: 17–20
Obata S, Sago H, Mori N, Rochelle JM, Seldin MF, Davidson M, St John T, Taketani S and Suzuki ST (1995) Protocadherin Pcdh2 shows properties similar to, but distinct from those of the classical cadherins. J Cell Sci 108: 3765–3773
Oshika Y, Nakamura M, Tokunaga T, Ozeki Y, Fukushima Y, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Tamaoki N and Ueyama Y (1998). Int J Oncol 12: 541–544
Paul R, Ewing CM, Robinson JC, Marshall FF, Johnson KR, Wheelock MJ and Saac WB (1997) Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma. Cancer Res 57: 2741–2748
Pawelec G, Rees RC, Kiessling R, Madrigal A, Dodi A, Baxevanis C, Gambacorti-Passerini C, Masucci G and Zeuthen J (1999) Cells and cytokines in immunotherapy and gene therapy of cancer. Crit Rev Oncog 10: 83–127
Pitzer C, Stassar M and Zöller M (1999) Identification of renal-cell-carcinoma-related cDNA clones by suppression subtractive hybridization. J Cancer Res Clin Oncol 125: 487–492
Raju KS, Alessandri G, Ziche M and Gullino PM (1982) Ceruloplasmin, copper ions and angiogenesis. J Natl Cancer Inst 69: 1183–1188
Ravaud A and Debled M (1999) Present achievements in the medical treatment of metastatic renal cell carcinoma. Crit Rev Oncol Hematol 31: 77–87
Reis M and Faria V (1994) Renal carcinoma: clinical, diagnostic and prognostic aspects. Arch Esp Urol 47: 739–743
Rosen L (2000) Antiangiogenic strategies and agents in clinical trials. Oncologist 5, (Suppl 1):20–27
Sahin U, Türeci Ö, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810–11813
Sargent ER, Gomella LG, Belldegrun A, Linehan WM and Kasid A (1989) Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. J Urol 142: 1364–1368
Shimazui T, Oosterwijk-Wakka J, Akaza H, Bringuir PP, Ruijter E, Debruyne FM, Schalken JA and Oosterwijk E (2000) Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma. Eur Urol 38: 331–338
Shimoyama Y, Gotoh M, Terasaki T, Kitajima M and Hirohashi S (1995) Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells. Cancer Res 55: 2206–2211
Somers KD and Schechter GL (1992) Genetic alterations in head and neck cancer. Otolaryngol Clin North Am 25: 1065–1071
Stasser M, Pitzer C and Zoller M (1999) Down-regulation of TNF receptor-associated protein–2/p 97 in renal cell carcinoma. Oncology Res 11: 85–90
Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E and Liotta LA (1992) Identification, purification and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267: 2524–2529
Stracke ML, Clair T and Liotta LA (1997) Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul 37: 135–144
Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R and Wapnir I (1994) Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Treat 31: 357–370
Tian H, McKnight SL and Russell DW (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11: 72–82
Tomisawa M, Tokunaga T, Oshika Y, Tsuchida T, Fukushima Y, Sato H, Kijima H, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M (1999) Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumor stage and vascularisation in renal cell carcinoma. Eur J Cancer 35: 133–137
Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG and Kerbel RS (1999) Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264: 781–788
Ullrich A and Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212
Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G and Citron M (1999) β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735–741
Vaupel PW (1997) The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia. Klin Padiatr 209: 243–249
Wang RF and Rosenberg SA (1999) Human tumor antigens for cancer vaccine development. Immunol Rev 170: 85–100
Weidner N (1995) Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9–19
Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323–330
Weiss H, Friedrich T, Hofhaus G and Preis D (1991) The respiratory chain NADH dehydrogenase (complex I) of mitochondria. Eur J Biochem 196: 563–576
Wen Y and Shatkin AJ (1999) Transcription elongation factor hSPT5 stimulates mRNA capping. Genes Dev 13: 1774–1779
Wiesener MS, Turley H, Allen WE, William C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ and Maxwell PH (1997) Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1 alpha. Blood 92: 2260–2268
Williamson JR, Chang K, Rowold E, Marvel J, Tomlinson M, Sherman WR, Ackermann KE and Kilo C (1985) Sorninil prevents diabetes-induced increases in vascular permeability but does not after collagen-cross-linking. Diabetes 37: 703–705
Xin H, Stephans JC, Duan X, Harrowe G, Kim E, Grieshammer U, Kingsley C and Giese K (2000) Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines. Biochim Biophys Acta 1501: 125–137
Yamaguchi Y, Narita T, Inukai N, Wada T and Handa H (2001) Spt genes: key players in the regulation of transcription, chromatin structure and other cellular processes. J Biochem 129: 185–191
Yang Y, Mou L, Liu N and Tsao MS (1999) Autotaxin expression in non-small-cell lung cancer. Am J Respir Cell Mol Biol 21: 216–222
Yoshida K, Tosaka A, Takeuchi S and Kobayashi N (1994) Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 73: 1913–1918
Yu AE, Hewitt RE, Conner EW and Stetler-Stevenson WG (1997) Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging 11: 229–244
Zhang SY, Caamano J, Cooper F, Guo X and Klein-Szanto AJ (1994) Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102: 695–698
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Stassar, M., Devitt, G., Brosius, M. et al. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 85, 1372–1382 (2001). https://doi.org/10.1054/bjoc.2001.2074
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2074
Keywords
This article is cited by
-
PCDH8 is a novel prognostic biomarker in thyroid cancer and promotes cell proliferation and viability
Functional & Integrative Genomics (2024)
-
Role of autotaxin in cancer stem cells
Cancer and Metastasis Reviews (2018)
-
Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer
Nature Communications (2016)
-
Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression
Medical Oncology (2016)
-
Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade
Arthritis Research & Therapy (2014)